A375 melanoma cell line was also engineered to co-express NY-ESO-1 as well as its matching MHC molecule, HLA-A2, to serve as the human tumor target (Supplementary Figure S1C,D) [28]. This evidence concerns the gene HLA-C and neoplasm.